This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Stocks With Big Insider Buying

Opko Health

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another biotech stock whose insiders are doing some big buying in is Opko Health (OPK), which is focused on developing a range of solutions, including molecular diagnostics tests, pharmaceuticals and vaccines. Opko operates in two segments: pharmaceutical and instrumentation segments. Insiders are paying up here to own shares of this name since the stock is up over 10% so far in 2011.

Opko Health has a market cap of $1.2 billion and an enterprise value of $1.1 billion. This company is currently not profitable yet. Its operating cash flow is -$21.1 million, and its levered free cash flow is -$22 million. Opko is cash-rich, however, with $107.86 million in cash on its books and just $14.55 million in debt. After you back out the debt, that gives the company $93.31 million in cash.

The CEO, chairman of the board and director just bought 100,000 shares, or $412,064 worth of stock, at $4.12 per share. This same CEO has been steadily buying millions worth of OPK stock since 2010. It's hard to make a bearish case against a stock where the CEO has been buying up shares as consistently as at OPK.

From a technical standpoint, this stock is trading above both its 50-day and 200-day moving averages, which is bullish. The stock has also been making higher lows and higher highs since the middle of June, which shows that the trend is positive.

If you're looking to get long OPK, I would wait until the stock breaks out above some near-term overhead resistance at around $4.40 to $4.50 a share. I would then add aggressively to any long position if you see OPK trigger a major breakout above $5.03 a share on solid volume. Look for a volume move that registers close to or over the three-month average action of 988,000 shares. Another way to play this name would be to buy it on any weakness as long as it holds above its 50-day ($3.83) and 200-day ($3.72) moving averages.

It's worth mentioning that OPK has a decent amount of short-sellers involved in the stock. The current short interest as a percentage of the float for OPK stands at 8%. If you see this stock break out, then expect a sharp short-covering rally to ensue as the bears peel off some of their bets.

5 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs